IL145637A0 - C7 carbonate substituted taxanes as antitumor agents - Google Patents

C7 carbonate substituted taxanes as antitumor agents

Info

Publication number
IL145637A0
IL145637A0 IL14563701A IL14563701A IL145637A0 IL 145637 A0 IL145637 A0 IL 145637A0 IL 14563701 A IL14563701 A IL 14563701A IL 14563701 A IL14563701 A IL 14563701A IL 145637 A0 IL145637 A0 IL 145637A0
Authority
IL
Israel
Prior art keywords
antitumor agents
carbonate substituted
substituted taxanes
taxanes
carbonate
Prior art date
Application number
IL14563701A
Other languages
English (en)
Original Assignee
Univ Florida State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida State Res Found filed Critical Univ Florida State Res Found
Publication of IL145637A0 publication Critical patent/IL145637A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Epoxy Compounds (AREA)
IL14563701A 2000-02-02 2001-02-02 C7 carbonate substituted taxanes as antitumor agents IL145637A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17967100P 2000-02-02 2000-02-02
PCT/US2001/003554 WO2001057030A1 (en) 2000-02-02 2001-02-02 C7 carbonate substituted taxanes as antitumor agents

Publications (1)

Publication Number Publication Date
IL145637A0 true IL145637A0 (en) 2002-06-30

Family

ID=22657501

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14563701A IL145637A0 (en) 2000-02-02 2001-02-02 C7 carbonate substituted taxanes as antitumor agents

Country Status (25)

Country Link
US (3) US6780879B2 (pt)
EP (1) EP1165552A1 (pt)
JP (1) JP2003522170A (pt)
KR (1) KR20010112395A (pt)
CN (1) CN1362958A (pt)
AU (1) AU776122B2 (pt)
BG (1) BG64890B1 (pt)
BR (1) BR0104351A (pt)
CA (1) CA2368540A1 (pt)
CZ (1) CZ20013429A3 (pt)
GE (1) GEP20043226B (pt)
HK (1) HK1047934A1 (pt)
HU (1) HUP0200756A3 (pt)
IL (1) IL145637A0 (pt)
MX (1) MXPA01009906A (pt)
NO (1) NO20014755L (pt)
NZ (1) NZ514380A (pt)
PL (1) PL350315A1 (pt)
RO (1) RO121271B1 (pt)
RU (1) RU2265019C2 (pt)
SK (1) SK13702001A3 (pt)
TR (1) TR200102857T1 (pt)
UA (1) UA74331C2 (pt)
WO (1) WO2001057030A1 (pt)
ZA (1) ZA200108051B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649632B2 (en) * 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
JP2003522170A (ja) * 2000-02-02 2003-07-22 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド 抗腫瘍剤としてのc7カーボネート置換タキサン
US7390898B2 (en) 2002-08-02 2008-06-24 Immunogen Inc. Cytotoxic agents containing novel potent taxanes and their therapeutic use
EP1534674A4 (en) 2002-08-02 2007-11-28 Immunogen Inc CYTOTOXIC AGENTS CONTAINING NEW, EFFECTIVE TAXANES AND THEIR THERAPEUTIC USE
SV2006002010A (es) * 2004-02-13 2006-08-23 Univ Florida State Res Found Taxanos sustituidos con esteres de ciclopentilo en c10
JP2008530122A (ja) * 2005-02-14 2008-08-07 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド C10シクロプロピルエステル置換タキサン組成物
EP2276755A4 (en) * 2008-03-31 2011-05-04 Univ Florida State Res Found C (10) -ETHYESTER- AND C (10) -CYCLOPROPYLESTER-SUBSTITUTED TAXANES

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US5175315A (en) 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
MX9102128A (es) 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
US5430160A (en) 1991-09-23 1995-07-04 Florida State University Preparation of substituted isoserine esters using β-lactams and metal or ammonium alkoxides
SG46582A1 (en) 1991-09-23 1998-02-20 Univ Florida State 10-Desacetoxytaxol derivatives
US5243045A (en) 1991-09-23 1993-09-07 Florida State University Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
US5714513A (en) 1991-09-23 1998-02-03 Florida State University C10 taxane derivatives and pharmaceutical compositions
US5283253A (en) 1991-09-23 1994-02-01 Florida State University Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
US5721268A (en) 1991-09-23 1998-02-24 Florida State University C7 taxane derivatives and pharmaceutical compositions containing them
US5227400A (en) 1991-09-23 1993-07-13 Florida State University Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
DE69333675T2 (de) 1992-01-15 2006-02-02 E.R. Squibb & Sons, Inc. Enzymatische Verfahren zur Trennung von Enantiomerengemischen von Verbindungen, die als Zwischenprodukte zur Herstellung von Taxanen nützlich sind
FR2687150B1 (fr) 1992-02-07 1995-04-28 Rhone Poulenc Rorer Sa Procede de preparation de derives du taxane.
US5272171A (en) 1992-02-13 1993-12-21 Bristol-Myers Squibb Company Phosphonooxy and carbonate derivatives of taxol
US5698712A (en) 1992-03-06 1997-12-16 Indena S.P.A. Baccatine III derivatives
US5939561A (en) 1992-03-10 1999-08-17 Rhone-Poulence Rorer S.A. Process for the preparation of β-phenylisoserine and β-lactam and their analogues
US5470866A (en) 1992-08-18 1995-11-28 Virginia Polytechnic Institute And State University Method for the conversion of cephalomannine to taxol and for the preparation of n-acyl analogs of taxol
US5319112A (en) 1992-08-18 1994-06-07 Virgnia Tech Intellectual Properties, Inc. Method for the conversion of cephalomannine to taxol and for the preparation of N-acyl analogs of taxol
IL107950A (en) 1992-12-15 2001-04-30 Upjohn Co b 7, b 8 - Matano - Taxols, their preparation and pharmaceutical preparations against malignant tumors containing them
MX9308012A (es) 1992-12-24 1994-08-31 Bristol Myers Squibb Co Eteres fosfonooximetilicos de derivados de taxano, solubles en agua y composiciones farmaceuticas que los incluyen.
EP1260507A1 (en) * 1993-02-05 2002-11-27 Bryn Mawr College Synthesis of taxol, analogs and intermediates with variable A-nng side chains
US5703247A (en) 1993-03-11 1997-12-30 Virginia Tech Intellectual Properties, Inc. 2-Debenzoyl-2-acyl taxol derivatives and methods for making same
US5475011A (en) 1993-03-26 1995-12-12 The Research Foundation Of State University Of New York Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
US5965739A (en) * 1993-06-11 1999-10-12 Pharmacia & Upjohn Company Δ6,7 -taxols antineoplastic use and pharmaceutical compositions containing them
IL109926A (en) 1993-06-15 2000-02-29 Bristol Myers Squibb Co Methods for the preparation of taxanes and microorganisms and enzymes utilized therein
TW397866B (en) 1993-07-14 2000-07-11 Bristol Myers Squibb Co Enzymatic processes for the resolution of enantiomeric mixtures of compounds useful as intermediates in the preparation of taxanes
CA2129288C (en) 1993-08-17 2000-05-16 Jerzy Golik Phosphonooxymethyl esters of taxane derivatives
FR2711369B1 (fr) 1993-10-20 1995-11-17 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions qui les contiennent.
WO1995011020A1 (en) * 1993-10-20 1995-04-27 Enzon, Inc. 2'- and/or 7- substituted taxoids
US5824701A (en) * 1993-10-20 1998-10-20 Enzon, Inc. Taxane-based prodrugs
EP0788493A1 (en) 1994-10-28 1997-08-13 The Research Foundation Of State University Of New York Taxoid derivatives, their preparation and their use as antitumor agents
US5801191A (en) 1995-06-01 1998-09-01 Biophysica Foundation Taxoids
TW354293B (en) 1995-06-06 1999-03-11 Bristol Myers Squibb Co Prodrugs of paclitaxel derivatives
US5780653A (en) 1995-06-07 1998-07-14 Vivorx Pharmaceuticals, Inc. Nitrophenyl, 10-deacetylated substituted taxol derivatives as dual functional cytotoxic/radiosensitizers
CA2231837A1 (en) 1995-09-13 1997-03-20 Florida State University Radiosensitizing taxanes and their pharmaceutical preparations
IL126856A0 (en) 1996-05-06 1999-09-22 Univ Florida State 1-Deoxy baccatin iii 1-deoxy taxol and 1-deoxy taxol analogs and method for the preparation thereof
US5811452A (en) 1997-01-08 1998-09-22 The Research Foundation Of State University Of New York Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof
US5912264A (en) 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
US7288665B1 (en) 1997-08-18 2007-10-30 Florida State University Process for selective derivatization of taxanes
WO2001057013A1 (en) 2000-02-02 2001-08-09 Florida State University Research Foundation, Inc. Taxane formulations having improved solubility
RU2264400C2 (ru) * 2000-02-02 2005-11-20 Флорида Стейт Юниверсити Рисерч Фаундейшн, Инк. Таксан, фармацевтическая композиция на его основе и способ ингибирования роста опухоли
US6649632B2 (en) * 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
US6638973B2 (en) * 2000-02-02 2003-10-28 Fsu Research Foundation, Inc. Taxane formulations
JP2003522170A (ja) 2000-02-02 2003-07-22 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド 抗腫瘍剤としてのc7カーボネート置換タキサン

Also Published As

Publication number Publication date
PL350315A1 (en) 2002-12-02
US7226944B2 (en) 2007-06-05
US6992104B2 (en) 2006-01-31
US20040138267A1 (en) 2004-07-15
UA74331C2 (uk) 2005-12-15
CN1362958A (zh) 2002-08-07
CZ20013429A3 (cs) 2002-04-17
BR0104351A (pt) 2002-01-02
BG64890B1 (bg) 2006-08-31
JP2003522170A (ja) 2003-07-22
SK13702001A3 (sk) 2002-06-04
HK1047934A1 (zh) 2003-03-14
GEP20043226B (en) 2004-04-26
HUP0200756A3 (en) 2005-02-28
NZ514380A (en) 2005-03-24
NO20014755L (no) 2001-11-29
NO20014755D0 (no) 2001-10-01
KR20010112395A (ko) 2001-12-20
WO2001057030A1 (en) 2001-08-09
MXPA01009906A (es) 2003-07-28
AU3479301A (en) 2001-08-14
AU776122B2 (en) 2004-08-26
BG105966A (en) 2002-07-31
CA2368540A1 (en) 2001-08-09
ZA200108051B (en) 2003-12-01
US20050165051A1 (en) 2005-07-28
TR200102857T1 (tr) 2002-06-21
HUP0200756A2 (hu) 2002-07-29
RO121271B1 (ro) 2007-02-28
RU2265019C2 (ru) 2005-11-27
US6780879B2 (en) 2004-08-24
EP1165552A1 (en) 2002-01-02
US20020065304A1 (en) 2002-05-30

Similar Documents

Publication Publication Date Title
MXPA01009901A (es) Taxanos sustituidos con ester en c7 como agentes antitumor.
EP1341554A4 (en) COMPOSITION IN COLOSTRUM BASIS
EP1270611A4 (en) COMPOSITION
PL350028A1 (en) C10 carbonate substituted taxanes as antitumor agents
PL350315A1 (en) C7 carbonate substituted taxanes as antitumor agents
HUP0200752A2 (en) C7 carbamoyloxy substituted taxanes as antitumor agents
AU2001287852A8 (en) Composition
HUP0600302A2 (en) C10 ester substituted taxanes as antitumor agents
GB0007762D0 (en) Composition
HUP0103247A3 (en) C7 ester substituted taxanes
ZA200106335B (en) C7 ester substituted taxanes.
GB0027048D0 (en) Shield
PL358229A1 (en) Sponge antitumor compounds
TW483347U (en) Improved toy structure for luminous toy
GB0002320D0 (en) Composition
GB0001939D0 (en) Composition
GB0014187D0 (en) Composition
GB0008118D0 (en) Composition
GB0020916D0 (en) Composition
GB0014971D0 (en) Composition
GB0020913D0 (en) Composition
GB0002115D0 (en) Composition
GB0000845D0 (en) Composition
GB0000792D0 (en) Composition
GB0000676D0 (en) Composition